Abstract:Background: Although its immunomodulatory properties make thymopentin (TP5) appealing, its rapid metabolism and inactivation in the digestive system pose significant challenges for global scientists. PEGylated niosomal nanocarriers are hypothesized to improve the physicochemical stability of TP5, and to enhance its intestinal permeability for oral administration. Methods: TP5-loaded PEGylated niosomes were fabricated using the thin film hydration method. Co-cultured Caco-2 and HT29 cells with different ratios were screened as in vitro intestinal models. The cytotoxicity of TP5 and its formulations were evaluated using an MTT assay. The cellular uptake and transport studies were investigated in the absence or presence of variable inhibitors or enhancers, and their mechanisms were explored. Results and Discussion: All TP5 solutions and their niosomal formulations were nontoxic to Caco-2 and HT-29 cells. The uptake of TP5-PEG-niosomes by cells relied on active endocytosis, exhibiting dependence on time, energy, and concentration, which has the potential to significantly enhance its cellular uptake compared to TP5 in solution. Nevertheless, cellular transport rates were similar between TP5 in solution and its niosomal groups. The cellular transport of TP5 in solution was carried out mainly through MRP5 endocytosis and a passive pathway and effluxed by MRP5 transporters, while that of TP5-niosomes and TP5-PEG-niosomes was carried out through adsorptive- and clathrin-mediated endocytosis requiring energy. The permeability and transport rate was further enhanced when EDTA and sodium taurocholate were used as the penetration enhancers. Conclusions: This research has illustrated that PEG-niosomes were able to enhance the cellular uptake and maintain the cellular transport of TP5. This study also shows this formulation's potential to serve as an effective carrier for improving the oral delivery of peptides.

Chitosan–glutathione Conjugate-Coated Poly(butyl Cyanoacrylate) Nanoparticles: Promising Carriers for Oral Thymopentin Delivery

Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.

Research on Thymopentin Loaded Oral N-trimethyl Chitosan Nanoparticles.

Preparation and Evaluation of Poly-Butylcyanoacrylate Nanoparticles for Oral Delivery of Thymopentin

Study on Preparation Release in Vitro and Biological Activity of Thymopentin-Loaded Ph-Sensitive Chitosan Nanoparticles for Oral Administration

[Research on Thymopentin-Loaded N-trimethyl Chitosan Nanoparticles Administered Through Mouth].

Preparation and Physical Characterization of Poly-Lactic-co-glycolic Acid Nanoparticles Loaded with Thymopentin for Oral Administration

Cellular Uptake and Transport Mechanism Investigations of PEGylated Niosomes for Improving the Oral Delivery of Thymopentin

Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.

Thymopentin Nanoparticles Engineered with High Loading Efficiency, Improved Pharmacokinetic Properties, and Enhanced Immunostimulating Effect Using Soybean Phospholipid and PHBHHx Polymer.

Preparation and In Vitro and In Vivo Evaluation Of Panax Notoginseng Saponins-loaded Nanoparticles Coated with Trimethyl Chitosan Derivatives

Optimizing the Preparation of Thymopentin Loaded Oral N-trimethyl Chitosan Nanoparticles by Central Composite Design

Mechanisms of Chitosan-Coated Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Improving Oral Absorption of 7-Ethyl-10-hydroxycamptothecin

Preparation of Thermosensitive Chitosan Formulations Containing 5-Fluorouracil/poly-3-hydroxybutyrate Microparticles Used As Injectable Drug Delivery System

Preparation, characterization and in vivo pharmacodynamic evaluation of thymopentin loaded poly(lactide acid)/poly(lactide-co-glycolide acid) implants.

Preparation and Characterization of Thymopentin Loaded Trimethyl Chitosan Submicron

Phenylboronic Acid-Functionalized Chitosan for Enabling Transmucosal Delivery for Cancer Therapy

Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel

Novel Strategy for Immunomodulation: Dissolving Microneedle Array Encapsulating Thymopentin Fabricated by Modified Two-Step Molding Technology.

Enhanced Antitumor Efficacy of Glutathione-Responsive Chitosan Based Nanoparticles Through Co-Delivery of Chemotherapeutics, Genes, and Immune Agents.

Design and fabrication of TPP cross-linked chitosan hydrogels with tunable stimuli-responsive properties and their application on drug delivery